Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Artificial intelligence for neurodegenerative experimental models.

Marzi SJ. et al, (2023), Alzheimers Dement

Artificial intelligence for biomarker discovery in Alzheimer’s disease and dementia

WINCHESTER L., (2023), Alzheimer's and Dementia

Interplay of Metabolome and Gut Microbiome in Individuals With Major Depressive Disorder vs Control Individuals.

Amin N. et al, (2023), JAMA Psychiatry, 80, 597 - 609

Harnessing the potential of machine learning and artificial intelligence for dementia research.

Ranson JM. et al, (2023), Brain Inform, 10

Identification of a possible proteomic Biomarker in Parkinson’s Disease: Discovery and Replication in Blood, brain and CSF

WINCHESTER L. and NEVADO-HOLGADO A., (2022), Brain Communications

Comparative effect of metformin versus sulfonylureas with dementia and Parkinson's disease risk in US patients over 50 with type 2 diabetes mellitus.

Newby D. et al, (2022), BMJ Open Diabetes Res Care, 10

The relationship between isolated hypertension with brain volumes in UK Biobank.

Newby D. et al, (2022), Brain Behav, 12

Validation of UK Biobank data for mental health outcomes: A pilot study using secondary care electronic health records.

Li Z. et al, (2022), Int J Med Inform, 160

The Relationship Between Isolated Hypertension with Brain Volumes in UK Biobank

NEWBY D., (2022), Brain and Behavior

Identification of a novel proteomic Biomarker in Parkinson’s Disease: Discovery and Replication in Blood, brain and CSF

Winchester L. et al, (2021)

Replication study of plasma proteins relating to Alzheimer's pathology.

Shi L. et al, (2021), Alzheimers Dement, 17, 1452 - 1464

High Blood Pressure and Risk of Dementia: A Two-Sample Mendelian Randomization Study in the UK Biobank.

Sproviero W. et al, (2021), Biol Psychiatry, 89, 817 - 824

Associations Between Brain Volumes and Cognitive Tests with Hypertensive Burden in UK Biobank.

Newby D. et al, (2021), J Alzheimers Dis, 84, 1373 - 1389

Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology.

Shi L. et al, (2020), J Alzheimers Dis, 77, 1353 - 1368

Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay.

Shi L. et al, (2019), Alzheimers Dement, 15, 1478 - 1488

CSF1R inhibitor JNJ-40346527 attenuates microglial proliferation and neurodegeneration in P301S mice.

Mancuso R. et al, (2019), Brain, 142, 3243 - 3264

Red blood cell indices and anaemia as causative factors for cognitive function deficits and for Alzheimer's disease.

Winchester LM. et al, (2018), Genome Med, 10

Commonly prescribed drugs associate with cognitive function: a cross-sectional study in UK Biobank.

Nevado-Holgado AJ. et al, (2016), BMJ Open, 6

Genomic alterations underlie a pan-cancer metabolic shift associated with tumour hypoxia.

Haider S. et al, (2016), Genome biology, 17, 140 - 140

Genomic alterations underlie a pan-cancer metabolic transcriptome shift

Haider S. et al, (2015), CANCER RESEARCH, 75

Include forthcoming?